科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
未登录
返回
J
J. Kusel
national institute for health and care excellence
10
H指数
120
论文数
309
被引数
0
相关解读
订阅
收录论文
44
发表时间
发表时间
IF
被引数
Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force
HTA决策中替代终点的评估方法:ISPOR工作组的一份良好实践报告
Value in Health
IF
6
2026-02-10
0
OA
AI
Sylwia Bujkiewicz; Oriana Ciani; Bart Heeg; Dawn Lee; Jeanette M. Kusel; Kristian Thorlund; Petros Pechlivanoglou; Stephen Stefani; Wanrudee Isaranuwatchai; Marc Buyse; Mario Ouwens
分享
收藏
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease
ADVANCES IN THERAPY
IF
4
2017-10-10
8
OA
AI
Hodgson, Robert; Reason, Timothy; Trueman, David; Wickstead, Rose; Kusel, Jeanette; Jasilek, Adam; Claxton, Lindsay; Taylor, Matthew; Pulikottil-Jacob, Ruth
分享
收藏
PAYERS, POLITICS AND PANDEMONIUM: AN INSIGHT INTO THE FUTURE UK PRICING AND MARKET ACCESS ENVIRONMENT
VALUE IN HEALTH
IF
6
2017-10-01
0
OA
AI
Spoors, J.; Kusel, J.
分享
收藏
MODEL TYPES SUBMITTED TO NICE: WHAT IS CONSIDERED APPROPRIATE BY EVIDENCE REVIEW GROUPS?
VALUE IN HEALTH
IF
6
2017-10-01
1
OA
AI
Hearmon, N. C.; Ghosh, W.; Buguth, B.; Kusel, J.
分享
收藏
COST-EFFECTIVENESS OF BARIATRIC SURGERY COMPARED TO CONVENTIONAL TREATMENT FROM A SOCIETAL PERSPECTIVE IN GERMANY, FRANCE, ITALY AND THE UK
VALUE IN HEALTH
IF
6
2017-10-01
0
OA
AI
Chen, G.; Kusel, J.; Buguth, B.; Higgins, A.; Belarbi, S.
分享
收藏
A VALUE FOR MONEY THRESHOLD FOR NEW TECHNOLOGIES FOR VERY RARE DISEASES: DOES THE NICE HIGHLY SPECIALISED COMMITTEE EMPLOY ONE?
VALUE IN HEALTH
IF
6
2016-11-01
0
OA
AI
Kusel, J.; Griffiths, S. A.; Spoors, J.
分享
收藏
PHARMACOLOGICAL INTERVENTIONS FOR FAMILIAL HYPERCHOLESTEROLAEMIA IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC LITERATURE REVIEW
VALUE IN HEALTH
IF
6
2016-11-01
0
OA
AI
Wickstead, R. M.; Evans, J. S.; Langford, B. E.; Beale, R. C.; Marsh, W.; Kusel, J.; Griffiths, M.
分享
收藏
THE COST-EFFECTIVENESS OF BARIATRIC SURGERY IN GERMANY, FRANCE, ITALY AND THE UNITED KINGDOM
VALUE IN HEALTH
IF
6
2016-11-01
0
OA
AI
Belarbi, S.; Kusel, J.; Thomas, M. G.
分享
收藏
PHARMACOLOGICAL INTERVENTIONS FOR FAMILIAL HYPERCHOLESTEROLAEMIA IN CHILDREN AND ADOLESCENTS: AN EXPLORATORY EVALUATION USING ADVANCED HIERARCHICAL NETWORK META-ANALYSIS TECHNIQUES
VALUE IN HEALTH
IF
6
2016-11-01
0
OA
AI
Langford, B. E.; Wickstead, R. M.; Marsh, W.; Beale, R. C.; Evans, J. S.; Kusel, J.; Griffiths, M.
分享
收藏
COST-EFFECTIVENESS OF BARIATRIC SURGERY COMPARED WITH NONSURGICAL TREATMENT OF MORBID OBESITY IN POLAND
VALUE IN HEALTH
IF
6
2016-11-01
0
PRE
AI
Szoka, B.; Batog, P.; Macioch, T.; Niewada, M.; Belarbi, S.; Kusel, J.; Wcislo, J.
分享
收藏
The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK
ADVANCES IN THERAPY
IF
4
2016-07-25
14
PRE
AI
Ghosh, Wrik; Wickstead, Rose; Claxton, Lindsay; Kusel, Jeanette; Taylor, Matthew; Fleetwood, Kelly; Pulikottil-Jacob, Ruth
分享
收藏
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK
APPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF
3.3
2016-04-29
2
PRE
AI
Montgomery, Stephen; Kusel, Jeanette; Allen, Felicity; Adlard, Nicholas
分享
收藏
REAL-WORLD DATA AND BUDGET IMPACT ANALYSIS FOR INCOBOTULINUM TOXIN A AND ONABOTULINUM TOXIN A FOR UPPER LIMB POST-STROKE SPASTICITY AT A UK CENTRE
VALUE IN HEALTH
IF
6
2015-11-01
0
OA
AI
Robertson, A.; Datta, P.; Kusel, J.; Page, S.; Soon, J.
分享
收藏
DOES BUDGET IMPACT AFFECT REIMBURSEMENT DECISIONS MADE BY THE CANCER DRUGS FUND IN ENGLAND?
VALUE IN HEALTH
IF
6
2015-11-01
0
OA
AI
Stewart, G.; Kusel, J.; Montgomery, S.
分享
收藏
THE ROLE OF EDUCATION IN THE MANAGEMENT OF TYPE 1 DIABETES MELLITUS IN ENGLAND
VALUE IN HEALTH
IF
6
2015-11-01
1
OA
AI
Toth, C. A.; Bridges, H. A.; Yang, L.; Stewart, G.; Kusel, J.
分享
收藏
SYSTEMATIC LITERATURE REVIEW (SLR) AND NETWORK META-ANALYSIS (NMA) OF TENOFOVIR/EMTRICITABINE (TDF/FTC) AND ABACAVIR/LAMIVUDINE (ABC/3TC) BACKBONE REGIMENS FOR HIV-1
VALUE IN HEALTH
IF
6
2015-11-01
0
PRE
AI
Agirrezabal, I; LeReun, C.; Eddowes, L. A.; Kusel, J.; Perard, R.
分享
收藏
THE COST-EFFECTIVENESS OF BARIATRIC SURGERY IN GERMANY
VALUE IN HEALTH
IF
6
2015-11-01
2
OA
AI
Belarbi, S.; Kusel, J.; Maruszczak, M.; Slater, D.; Thomas, M. G.; Martini, O.
分享
收藏
AN UNDEVELOPED PICTURE: THE AVAILABILITY OF UTILITY VALUATIONS IN LATIN AMERICA - HOW WILL THEY AFFECT QALYS?
VALUE IN HEALTH
IF
6
2015-11-01
0
OA
AI
Montgomery, S.; Stewart, G.; Kusel, J.
分享
收藏
COST-UTILITY OF FINGOLIMOD COMPARED WITH DIMETHYL FUMARATE (DMF) IN HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) IN ENGLAND: COMPARISON OF A MARKOV AND DISCRETE EVENT SIMULATION MODEL
VALUE IN HEALTH
IF
6
2015-11-01
4
OA
AI
Kusel, J.; Maruszczak, M.; Adlard, N.
分享
收藏
CONSIDERATIONS FOR THE ADOPTION OF THE WHO-CHOICE COST-EFFECTIVENESS THRESHOLD IN LATIN AMERICA
VALUE IN HEALTH
IF
6
2015-11-01
0
OA
AI
Griffiths, M.; Kusel, J.; Stewart, G.; Latchford, J.
分享
收藏
研究方向
暂时未获取到该数据
合作学者
合作期刊
M
Mark D. Griffiths
H 指数: 170 · 论文数: 2.4K
M
Mark Thomas
H 指数: 99 · 论文数: 970
G
Gane Ka‐Shu Wong
H 指数: 79 · 论文数: 287
S
Stephen J. Page
H 指数: 78 · 论文数: 685
M
Matthew Taylor
H 指数: 52 · 论文数: 439
查看更多